Suzhou Zelgen Stock Hits Day Low of CNY 86.29 Amid Price Pressure

Suzhou Zelgen Biopharmaceuticals Co., Ltd. experienced a notable decline today, with the stock dropping by 3.82% and reaching an intraday low of CNY 86.29. This performance contrasts sharply with the China Shanghai Composite, which recorded a modest gain of 0.4% on the same day. Over the past week, Suzhou Zelgen has seen a decrease of 6.44%, and its monthly performance reflects a significant drop of 15%. Year-to-date, the stock has declined by 6.15%, while its one-year performance shows a substantial loss of 24.18%. In contrast, the China Shanghai Composite has gained 21.28% over the past year. Despite these challenges, the company has reported positive results for the last four consecutive quarters, with net sales peaking at CNY 217.79 million. However, the stock's performance metrics indicate a concerning trend, including a low return on capital employed (ROCE) of 0% and a negative net worth. The market capitalization stands at CNY 23,096 million, and the stock is currently trading at a price-to-earnings ratio of 47.00.